Novel way to prevent medication errors
From the July
31, 1996 issue
PROBLEM: Although pharmaceutical companies and regulatory
agencies have been working on design changes to improve the
situation(1-2), ISMP still associates many medication errors
with confusion over "look-alike" or "sound-alike"
product names. Since patients receive the wrong drug, these
sometimes result in serious harm. A common cause of name mix-ups
is what human factors experts call "confirmation bias",
where a practitioner reads a poorly written drug name and
is most likely to see in that name that which is most familiar
to him, overlooking any disconfirming evidence. Although various
compilations of name pairs are available for posting, these
have only limited usefulness since it's impossible for practitioners
to memorize these long list s in order to know when to check
on questionable orders. Also, when confirmation bias occurs,
there is never a reason for the practitioner to question the
order to begin with.
SAFE PRACTICE RECOMMENDATION: In many cases you can
use your hospital or pharmacy computer system to reduce the
risk of confirmation bias and resulting name mix-ups. Many
systems have a "clinical flag" or "formulary
note" screen or field that can be easily adapted to include
important information prominently on the computer screen.
Similar to a road sign warning about a dangerous intersection
ahead, this feature can be used to alert the person inputting
the order when a look-alike or sound-alike danger is present.
At the Erie County Medical Center in Buffalo, New York, for
example, when NorvascO is entered into the computer, a formulary
note screen appears, alerting the pharmacist that Norvasc(r)
often looks like NavaneO when handwritten. The pharmacist
will then take the necessary steps to confirm the order if
necessary. A formulary note has been added for more than 100
name pairs. By prompting pharmacists, or nurses or unit clerks
who enter orders, serious medication errors can be prevented.
To get started, a list of problem name pairs is available
from USP. Call 800-227-8772. Also, be sure to use the biweekly
"Safety Briefs" and drug name problem alerts that
appear in many of the ISMP Medication Safety Alert! issues
in order to keep the information up to date. [N,P,Q]
References: 1. Boring D et al. Avoiding trademark trouble
at FDA. Pharmaceutical Executive 1996;16:80-8; 2. Davis NM
et al. Lookalike and sound-alike drug names: The problem and
the solution. Hosp Pharm 1992;27:95-8, 102-5, 108-10
|